Cholesterol news | Breaking cholesterol news | Cholesterol

(AP) KFC to Switch to Oil With No Trans Fat

... Other companies including Wendy'sInternational Inc., Starbucks Corp., McDonald's Corp.

and Burger King Holdings Inc.

have also said they will phase out trans fat from their products.

KFC said the change in cooking oils will not change how its fried chicken tastes.

"We have safeguarded the recipe and the flavor profile," said Doug Hasselo, KFC's chief food innovation officer.

Hasselo said the new cooking oil costs more, but the chain will absorb the extra expense without passing it along to customers.

The zero grams trans fat items at KFC also include its potato wedges.

Some of KFC's non-fried items still contain trans fat, including biscuits, pot pies, macaroni andcheese, and some desserts.

The company said it's working to remove trans fat from those items.

KFC was unveiling television advertising Monday to promote its switch to cooking oil without trans fat.

KFC stores will put up signs touting the conversion, and the chicken buckets will carry the health message within a week or two.

The company won praise from the Center for Science in the Public Interest, a consumer group that pushed for KFC to switch to a healthier cooking oil.

"To get rid of this one major problem improves their customers' health automatically, without the consumers doing anything," said Michael Jacobson, the group's executivedirector.

Customers at a KFC restaurant in the chain's hometown said they appreciated the change.

Steve Garber, part ...

Studies yield no black-and-white verdict on coffee's benefits

...This finding emerged from a review of nine studies published in the July 6, 2005, issue of the Journal of the American Medical Association, but it conflicts with earlier evidence suggesting that coffee can reduce insulin sensitivity, which would increase the risk of diabetes.

To confuse matters further, a study published in the February 2006 issue of Diabetes Care found that decaf lowers the risk of diabetes, suggesting that something other than caffeine may be responsible for any protection coffee affords.As far as cancer is concerned, coffee might offer some protection, but no one knows how much.

A study published in the Feb.

16, 2005, issue of the Journal of the National Cancer Institute found a 52 per cent lower incidence of rectal cancer among people who regularly drank two or more cups of decaf a day.

Coffee contains some antioxidants, which can protect against cancer, but not enough of them to make up for risks posed by a poor diet.Other studies have suggested that coffee may protect against Parkinson's disease, but the evidence isn't strong enough to be certain.

In the largest study, among Japanese-American men in Honolulu, the more coffee the men drank, the lower their risk.

But no one can say whether those findings would hold true among women or even among men of other ethnic backgrounds.

Some studies have suggested that coffee also may protect against Alzheimer's disease, ...

Advagraf(R) Now Approved Across Europe as a Once-Daily ...

...About Advagraf(R) Advagraf(R) will be available as early as June 2007 in the UK andGermany, followed by launches in additional European countriesthroughout the year and in 2008.

About Astellas Astellas Pharma Europe Limited, located in the UK, is a Europeansubsidiary of Tokyo-based Astellas Pharma Inc.

Astellas is apharmaceutical company dedicated to improving the health of peoplearound the world through the provision of innovative and reliablepharmaceutical products.

The organisation is committed to becoming aglobal pharmaceutical company by combining outstanding R&D andmarketing capabilities and continuing to grow in the worldpharmaceutical market.

Astellas Pharma Europe is responsible for 19affiliate offices located across Europe, the Middle East and Africa,2 R&D establishments and 3 manufacturing plants with approximately3,000 staff.

(1) Greenstein, S., Siegal B.

Compliance and Noncompliance inPatients with a Functioning Renal Transplant: A Multicenter Study.Transplantation 1998; 66(12): 1718-1726.

(2) Denhaerynck, K., Dobbels, F., Cleemput, I., et al.

Prevalence,consequences and determinants of nonadherence in adult renaltransplant patients: a literature review.

Transplant Int 2005;18(10): 1121-1133.

(3) Weng, FL., Israni, AK., Joffe, MM., et al.

Race andelectronically measured adherence to immunosuppressive medicationsafter deceased donor renal transplantation.

J Am Soc Nephrol 2005;16(6): ...

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | 99 | All news